ELV
Elevance Health Inc.
- Healthcare
- US companies in Healthcare (47)
- NYSE · USD
- Mkt cap $91.4bn
$421.49
as of 27 Oct 2026, 6% below its 52-week high
Screens as well placed to keep growing its dividend, with low cut-risk signals.
These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.
- Trailing yield
- 1.63%Last 12 months of regular payments at today's price
- Forward yield
- 1.76%Each payment expected in the next 12 months, not the latest one doubled
- Earnings cover
- 3.4×Pays 29% of earnings
- Cash cover
- 4.3×Free cash flow over dividends paid
- 5y dividend growth
- +12.5% a yearNo cut since FY2012
- Next ex-dividend date
- Declared4 Dec 2026Quarterly dividend of $1.72
Compared with US companies in Healthcare (47)
- Trailing yield is higher than 31 of the 46 other US companies in Healthcare.
- 5y dividend growth (as paid) is higher than 31 of the 38 other US companies in Healthcare with a 5y growth figure.
Quality
90
HighCapacity to keep growing the dividend
Risk
0
LowSignals of dividend-cut pressure
Trim
42
LowHow extended the valuation looks
Why Risk is 0
ELV against US companies in Healthcare (47)
Valuation against its own history
As of the last reported period (30 Sept 2026). P80 means the figure is higher than 80% of ELV’s past readings.
- P/E16.5×P46, neutral for this measure
- Yield1.77%P84, good for this measure
- FCF payout23.0%P56, neutral for this measure
- Net debt / EBITDA2.30P65, neutral for this measure
- DGR 5y+9.6%P7, poor for this measure
- ROIC6.7%P24, poor for this measure
Forecast your income with the ELV dividend calculator
Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.